Remove Drug Delivery Systems Remove Marketing Remove Packaging Remove Regulation
article thumbnail

Pharmaceutical Polymers / Medical Polymers -Current Scenario and Future Potential

Roots Analysis

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Vaccine Adjuvants: Polymers often serve as carriers for releasing the antigen and thereby regulating the immunological responses.

article thumbnail

Pre-Filled Syringes East Coast 2022

pharmaphorum

Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. The global pre-filled syringes market was valued at $1139.6 Assess the evolving regulatory landscape for pre-filled syringes and discuss approaches to work with regulators as guidance is updated. Secondary packagers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Biodegradable Nanocellulose ECG Patch: The Sustainable Alternative

XTalks

The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The Global ECG Patch Market The global ECG patch and holter monitor market , estimated to be around $13 billion and projected to grow at a 17.5

article thumbnail

FDA Encourages Innovation in Medical Device Sterilization While Reducing Adverse Environmental Impacts

XTalks

By the end of this year, the EPA plans to propose an air pollution regulation to address EtO emissions at commercial sterilizers and to protect public health. XTALKS WEBINAR: ISO 11608: Best Practices to De-Risk & Shorten Time to Market for Wearable Injectors. The combination of supercritical carbon dioxide with 0.25

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

The demand for injectable drugs is rising. According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. Several drug development trends are driving injectables demand.

article thumbnail

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Pharmaceutical Technology

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.